Dr. Patt retweeted
The most practice changing trial from #ASCO25 is now live on @NEJM .If this was a drug, this would be approved today. Globally relevant and low-cost intervention that is not only delaying relapse but actually improving survival.
Perfect case example of a #cancergroundshot trial.
nejm.org/doi/full/10.1056/NE…
Dr. Patt retweeted
Proud to be part of this group of cancer health services researchers who are supporting a Young Investigator Award with the @ConquerCancerFd @ASCO. Now, more than ever, we must support rigorous research. #asco2025 @WinshipAtEmory
Join @ASCO Communities of practice
Health Policy Community of Practice at #ASCO25
Saturday, May 31, from 4:00 to 6:00 PM in Room S103
In a time of fluid policy change become engaged through this community. @JasmineKambojMD
So grateful for @FDAOncology @realrickpazdur for his tireless efforts to streamline regulatory processes, fostering collaboratio and innovation and getting safe and effective therapies to patients. #ASCO25 @ASCO @TheUSONetwork @jrgralow
Dr. Patt retweeted
Ready for #ASCO25? Here are the plenary highlights👇
1️⃣ #ATOMIC Ph. III (Alliance A021502) in early‐stage III dMMR colon CA, where adj mFOLFOX6 goes head-to-head with the same chemo + atezo. Prim endpoint is DFS, sec are OS + AEs. So far, no interim data—all eyes on this one! @FASinicropeMD
Excited to start #ASCO25 with @EMittendorfMD and Dr Sandy Swain! Come and see our talk on AI, clinical decision support, what ASCO is doing, and tools for the practice today 1pm in S100 and Saturday 4-6pm in S501. @dougfloramd @ASCO @TheUSONetwork
Dr. Patt retweeted
🚨 BREAKING | Press Release today
DESTINY-Breast11 🧪
Neoadjuvant Enhertu ➕ THP showed ⭐ statistically significant & clinically meaningful improvement in pCR vs ddAC➕THP
In high-risk ⚠️, locally advanced HER2+ 🧬 early breast cancer
Early EFS trend 📈 also favored Enhertu! @ErikaHamilton9 @OncoAlert @OncBrothers @Larvol @stolaney1
#BreastCancer #OncoTwitter 💊
Dr. Patt retweeted
Spectacular keynote by @DavidFajgenbaum of @upenn - he is the author of “@chasingmycure” and is working in the space of repurposing the existing drugs for challenging disease scenarios.
@oncologyCOA #COA2025 @dapattmd @HemOncFellows @HemOncWomenDocs @IMG_Oncologists
The ENERGY at the @oncologyCOA 2025 conference was infectious! Thank you to my @TexasOncology family for coming to support me and share knowledge. @TheUSONetwork @ASCO @ACCCBuzz
Excited to be @oncologyCOA annual conference with amazing leaders in community cancer care @BarbaraMcAneny
Register for the @oncologyCOA conference April 29-30 2025 in Orlando. This is the best way to collaborate with others in community oncology. I hope to see you there!
Dr. Patt retweeted
Did I seriously see a not very important regional health care system drop $8m on a Superbowl ad? And they say they're broke?
Great to be @avbcancercare with thought leaders in cancer care to come to better solutions together @TexasOncology @TheUSONetwork @FLCancerFound @weareOnCare
Inspired to be with my teenage son watching Starship make necessary progress to plan for a trip to Mars. The orbital stage rocket AND CATCH was incredible! @SpaceX @SpaceXStarship @StarshipGazer
While we have a heavy heart today remembering the events of Oct 7 and all of the destruction that has happened since, I appreciate the support and engagement from our community leaders @texasgov @GovAbbott @AgudasAchimATX 🙏🏻 for ☮️
So inspired @ASCO #ASCOQLTY24 where @EthanBasch1 enlightened us all to his vision of quality improvement in accepting the well deserved Joe Simone Quality Award. 🥇
Dr. Patt retweeted
The 2024 @df_hcc Breast Cancer Program Research Retreat - @DFCI_BreastOnc
oncodaily.com/blog/134555
@dapattmd @jhalamka @zakkohane
#Cancer #BCSM #Health #Medicine #MedTwitter #OncoDaily #Oncology
Dr. Patt retweeted
Medicare Drug Price Negotiation Program Will Result in Financial Burdens for Community Oncology Practices
@dapattmd @oncologyCOA @TexasOncology @TheUSONetwork @DellMedSchool
onclive.com/view/medicare-dr…


























